Trial · NCT01516957
Adverse events208
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 208
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Upper respiratory Tract Infection | Infections and infestations | Placebo SC | 8 | 52 | |
| other | Upper respiratory Tract Infection | Infections and infestations | AMG 827 140 | 14 | 53 | |
| other | Upper respiratory Tract Infection | Infections and infestations | AMG 827 280 | 11 | 51 | |
| other | Upper respiratory Tract Infection | Infections and infestations | Open Label 210 mg or 280 mg AMG 827 | 33 | 156 | |
| other | Nasopharyngitis | Investigations | Placebo SC | 9 | 52 | |
| other | Nasopharyngitis | Investigations | AMG 827 140 | 10 | 53 | |
| other | Nasopharyngitis | Investigations | AMG 827 280 | 10 | 51 | |
| other | Nasopharyngitis | Investigations | Open Label 210 mg or 280 mg AMG 827 | 29 | 156 | |
| other | urinary tract infection | Infections and infestations | Placebo SC | 5 | 52 | |
| other | urinary tract infection | Infections and infestations | AMG 827 140 | 10 | 53 | |
| other | urinary tract infection | Infections and infestations | AMG 827 280 | 8 | 51 | |
| other | urinary tract infection | Infections and infestations | Open Label 210 mg or 280 mg AMG 827 | 23 | 156 | |
| other | Bronchitis | Infections and infestations | Placebo SC | 6 | 52 | |
| other | Bronchitis | Infections and infestations | AMG 827 140 | 8 | 53 | |
| other | Bronchitis | Infections and infestations | AMG 827 280 | 7 | 51 | |
| other | Bronchitis | Infections and infestations | Open Label 210 mg or 280 mg AMG 827 | 21 | 156 | |
| other | Sinusitis | Infections and infestations | Placebo SC | 4 | 52 | |
| other | Sinusitis | Infections and infestations | AMG 827 140 | 8 | 53 | |
| other | Sinusitis | Infections and infestations | AMG 827 280 | 9 | 51 | |
| other | Sinusitis | Infections and infestations | Open Label 210 mg or 280 mg AMG 827 | 21 | 156 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01516957/events